Aton Pharma is a specialty pharmaceutical company focusing on ophthalmic diseases, orphan conditions, and acute care hospital products.
Aton Pharma, Inc. operates as a specialty pharmaceutical company. It focuses on ophthalmic diseases, orphan conditions, and acute care hospital products. The company offers products for metabolic, neurological, and cardiovascular diseases, as well as provides products for under-treated diseases, including dry eye. Its products include timolol maleate ophthalmic gel forming solution for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The company serves patients, caregivers, and healthcare professionals in the United States, the Asia Pacific region, Australia, and internationally. Aton Pharma, Inc. was formerly known as Avatar. The company was founded in 2001 and is based in Lawrenceville, New Jersey. Aton Pharma, Inc. is a former subsidiary of Merck & Co., Inc.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 10, 2003 | Private Equity(PE) | $13.70M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Perseus-Soros Biopharmaceutical Fund | — | Private Equity(PE) |